Clinical Trials
All Clinical Trials - Page 20 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT05963022Phase 3Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)
Tirzepatide
- NCT06143033N/ACompleted
A Clinical Trial to Evaluate the Effects of an Eye Serum on Improving the Appearance of the Periorbital Area
Argireline
- NCT05996848Phase 3Completed
A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight
Semaglutide
- NCT06085976Phase 2Unknown
Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.
Octreotide
- NCT05617885Phase 1Terminated
Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer
Gonadorelin
- NCT05971940Phase 3Completed
A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone
Orforglipron
- NCT05984238N/ACompleted
A Trial to Evaluate Safety, Feasibility and Efficacy of Endoscopic Duodenal PEF Therapy
Semaglutide
- NCT05931367Phase 3Completed
A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee
Retatrutide
- NCT05990374N/AUnknown
Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years
Tirzepatide
- NCT05897372Phase 2Terminated
Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study
Semaglutide
- NCT06025409Phase 3Unknown
Evaluate the Efficacy and Safety of DWJ108J
Gonadorelin
- NCT06091735N/ACompleted
Clinical Study of Bowel Preparation Before Colonoscopy
Linaclotide
- NCT05978713Phase 1Completed
A Study of Tirzepatide (LY3298176) in Healthy Lactating Females
Tirzepatide
- NCT05931380Phase 3Completed
A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease
Orforglipron
- NCT06005012Phase 2Active Not Recruiting
Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM
Semaglutide
- NCT06139419Phase 2Completed
The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC
Thymosin-Alpha-1
- NCT05936151Phase 2Completed
A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
Retatrutide
- NCT05945420Phase 4Unknown
Adding Desmopressin to Tamsulosin for Treatment of BPH
Desmopressin
- NCT05959096Phase 1Completed
A Study of LY3437943 in Healthy Participants With a High Body Mass Index
Retatrutide
- NCT05972902Phase 3Unknown
Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes
Gonadorelin
- NCT05916560Phase 1Completed
A Study of LY3437943 in Participants With Impaired and Normal Liver Function
Retatrutide
- NCT05936138Phase 1Completed
A Phase 1, Parallel, Single-Dose, Open-Label, Single-Period Study of LY3502970 in Participants With Normal Renal Function and Participants With Renal Impairment.
Orforglipron
- NCT05929079Phase 3Completed
A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
Retatrutide
- NCT05929066Phase 3Completed
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
Retatrutide
- NCT05812183Phase 4Withdrawn
Gastric Sleeve-Induced Weight Loss on Shortness of Breath in Obesity
Tirzepatide
- NCT05726227Phase 3Active Not Recruiting
A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight
Semaglutide
- NCT05884255Phase 3Recruiting
An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.
Octreotide
- NCT05872022N/AEnrolling By Invitation
A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy
Semaglutide
- NCT06354101N/AWithdrawn
The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Without Metabolic Diseases Are Expected to Participate in This Registry Study.
Tirzepatide
- NCT06219330N/ACompleted
Cathelicidin LL-37 Relation to Potentially Malignant Lesions
Ll-37
- NCT05701241Phase 4Recruiting
Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients
Octreotide
- NCT05877547Phase 2Completed
A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)
Semaglutide
- NCT05847283N/ARecruiting
DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Reserve Patients: An RCT
Gonadorelin
- NCT05819138Phase 3Recruiting
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
Semaglutide
- NCT05891496Phase 3Completed
A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease
Semaglutide
- NCT05925959N/ARecruiting
Preoperative Weight Loss for Open Abdominal Wall Reconstruction
Semaglutide
- NCT05922579N/ATerminated
A Study to Collect the Somatuline® Injector Device Preferences of Patients Living With Neuroendocrine Tumor (NET) and Nurses Involved in the Care of Patients With NET
Lanreotide
- NCT05895643Phase 2Completed
Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?
Semaglutide
- NCT05882032Phase 1Completed
A Study of LY3502970 in Participants With Impaired and Normal Liver Function
Orforglipron
- NCT05888961N/ARecruiting
Single-center Prospective Longitudinal Study of Taste in Patients With Cognitive Disorders at Different Stages of Severity (Isolated Cognitive Complaint, Minor or Major Neurocognitive Alzheimer-type Disorders) by Analysis of Gustatory Evoked Potentials
Ghrp-6
- NCT06120556N/ACompleted
Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes
Semaglutide
- NCT07104461N/ACompleted
Advanced Protein-based Program for Effective Treatment of Appetite Regulation and Obesity
Ghrp-6
- NCT05833217N/ARecruiting
Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2
Octreotide
- NCT05869903Phase 3Active Not Recruiting
A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Orforglipron
- NCT05872620Phase 3Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Orforglipron
- NCT05894486Phase 2Unknown
Phase II Study to Evaluate the Efficacy and Safety of 177Lu-Dotatate in the First-line Treatment of Patients With Locally Advanced or Metastatic, Somatostatin Receptor-positive G2 or G3 Gastroenteropancreatic Neuroendocrine Tumors
Octreotide
- NCT05493709Phase 3Completed
Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty
Gonadorelin
- NCT05756764N/AActive Not Recruiting
Anti-obesity Pharmacotherapy and Inflammation
Tirzepatide
- NCT05891093Phase 3Recruiting
Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)
Gonadorelin
- NCT05882045Phase 3Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Retatrutide